Sfoglia per Autore
Mostrati risultati da 1 a 8 di 8
A novel class of selective CK2 inhibitors targeting its open hinge conformation
2020 Dalle Vedove, Andrea; Zontab, Francesca; Zanforlin, Enrico; Demitri, Nicola; Ribaudo, Giovanni; Cazzanelli, Giulia; Ongaro, Alberto; Sarno, Stefania; Zagotto, Giuseppe; Battistutta, Roberto; Ruzzene, Maria; Lolli, Graziano
Design and Synthesis of Novel Chemical Entities with Anticancer Activity
2019 Zanforlin, Enrico
A chemical approach to overcome tyrosine kinase inhibitors resistance: learning from chronic myeloid leukemia
2019 Zanforlin, E.; Zagotto, G.; Ribaudo, G.
Semi-synthetic isoflavones as BACE-1 inhibitors against Alzheimer's disease
2019 Ribaudo, G.; Coghi, P.; Zanforlin, E.; Law, B. Y. K.; Wu, Y. Y. J.; Han, Y.; Qiu, A. C.; Qu, Y. Q.; Zagotto, G.; Wong, V. K. W.
Overcoming resistance in non-small-cell lung cancer: A practical lesson for the medicinal chemist
2018 Ribaudo, Giovanni; Zanforlin, Enrico; Zagotto, Giuseppe
Preliminary studies of berberine and its semi-synthetic derivatives as a promising class of multi-target anti-parkinson agents
2018 Ribaudo, Giovanni; Zanforlin, Enrico; Canton, Marcella; Bova, Sergio; Zagotto, Giuseppe
The Medicinal Chemistry of Natural and Semisynthetic Compounds against Parkinson's and Huntington's Diseases
2017 Zanforlin, Enrico; Zagotto, Giuseppe; Ribaudo, Giovanni
An overview of new possible treatments of Alzheimer's disease, based on natural products and semi-synthetic compounds
2017 Zanforlin, E.; Zagotto, G.; Ribaudo, G.
Mostrati risultati da 1 a 8 di 8
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile